Clinical Trials for Alpha Tau Medical

Explore 24 clinical trials worldwide

Showing 1-24 of 24 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Alpha Tau Medical

Clinical Trials (24)

NCT06615635
Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients
NANot yet recruiting
28 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2026
6 conditions1 sponsor11 locations
NCT06910306
A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma
NANot yet recruiting
10 participants
Started: Sep 1, 2025 · Completed: Dec 1, 2026
2 conditions1 sponsor1 location
NCT06698458
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
NARecruiting
30 participants
Started: Jun 17, 2025 · Completed: Dec 31, 2026
3 conditions1 sponsor16 locations
NCT06755359
Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer
NANot yet recruiting
40 participants
Started: Apr 30, 2025 · Completed: Jun 30, 2027
2 conditions1 sponsor12 locations
NCT05065346
Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC
NANot yet recruiting
79 participants
Started: Mar 31, 2025 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT06026943
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer
NANot yet recruiting
15 participants
Started: Jan 31, 2025 · Completed: Jan 31, 2028
3 conditions1 sponsor0 locations
NCT06202339
Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).
NANot yet recruiting
10 participants
Started: Apr 30, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor0 locations
NCT06202248
A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer
NARecruiting
10 participants
Started: Mar 12, 2024 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT06202118
A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.
NARecruiting
10 participants
Started: Feb 19, 2024 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT05829291
Alpha Radiation Emitters Device for the Treatment of Liver Metastases (DaRT)
NARecruiting
10 participants
Started: Oct 1, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05657743
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer
NARecruiting
15 participants
Started: Aug 16, 2023 · Completed: Nov 30, 2025
4 conditions1 sponsor2 locations
NCT05632913
Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer
NARecruiting
10 participants
Started: Jul 1, 2023 · Completed: Feb 28, 2027
2 conditions1 sponsor1 location
NCT05781555
A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors
NARecruiting
100 participants
Started: Mar 22, 2023 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT04761146
A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer
NARecruiting
10 participants
Started: Feb 28, 2023 · Completed: Jan 1, 2026
3 conditions2 sponsors1 location
NCT05323253
A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma
NARecruiting
86 participants
Started: Sep 21, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor31 locations
NCT04543903
Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer
NARecruiting
10 participants
Started: May 16, 2022 · Completed: May 1, 2027
1 condition1 sponsor3 locations
NCT04068155
Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors
NARecruiting
80 participants
Started: Apr 1, 2022 · Completed: Jan 31, 2025
3 conditions1 sponsor2 locations
NCT05047094
A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC
NARecruiting
48 participants
Started: Nov 2, 2021 · Completed: Jun 30, 2027
3 conditions1 sponsor3 locations
NCT03886181
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)
NARecruiting
35 participants
Started: Jul 8, 2021 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT04534127
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
NARecruiting
56 participants
Started: Dec 22, 2020 · Completed: Jan 1, 2026
3 conditions1 sponsor1 location
NCT04540588
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
NARecruiting
39 participants
Started: Dec 22, 2020 · Completed: Jan 1, 2026
3 conditions1 sponsor1 location
NCT03889899
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
NARecruiting
30 participants
Started: Oct 21, 2020 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT04002479
Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer
NARecruiting
37 participants
Started: Oct 20, 2020 · Completed: Oct 31, 2026
4 conditions1 sponsor2 locations
NCT03737734
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)
NAActive, not recruiting
30 participants
Started: Dec 31, 2018 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location